MaxCyte
MXCT
2,16 €
Share price
-4.74%
Change (1 day)
-43.38%
Change (1 year)
Categories
P/S ratio for MaxCyte (MXCT)
P/S ratio as of April 2025 (TTM): 6.94
According to MaxCyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.30. At the end of 2024 the company had a P/S ratio of 11.4.
P/S ratio history for MaxCyte from 2021 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 11.4 | -3.42% |
| 2023 | 11.8 | -6.34% |
| 2022 | 12.6 | -58.63% |
| 2021 | 30.4 |